HF
ATRA icon

HRT Financial’s Atara Biotherapeutics ATRA Stock Holding History

HRT Financial’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,691
Closed -$60K – 2298
2023
Q4 		$60K Buy
+4,691
New +$109K ﹤0.01% 1937
2023
Q3 		– Sell
-6,477
Closed -$260K – 2381
2023
Q2 		$260K Buy
+6,477
New +$366K ﹤0.01% 1712
2023
Q1 		– Sell
-1,790
Closed -$146K – 2474
2022
Q4 		$146K Sell
1,790
-3,623
-67% -$378K ﹤0.01% 2003
2022
Q3 		$511K Buy
+5,413
New +$608K 0.01% 1424
2021
Q3 		– Sell
-693
Closed -$269K – 3259
2021
Q2 		$269K Buy
+693
New +$247K ﹤0.01% 2214
2020
Q1 		– Sell
-1,961
Closed -$807K – 767
2019
Q4 		$807K Buy
+1,961
New +$676K 0.03% 400

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return